
Recapping Every FDA Approval Announced in April for Cancer Care
During the month of April 2025, the U.S. Food and Drug Administration (FDA) announced the approval of several agents and combination therapies in the field of oncology across indications including breast cancer, ovarian cancer, nasopharyngeal carcinoma, as …